Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Adherium Ltd. ( (AU:ADR) ) just unveiled an announcement.
Adherium Limited announced a delay in lodging the Appendix 3H with the ASX due to an administrative oversight, which the company views as an isolated incident. Despite this, Adherium maintains confidence in its compliance practices with ASX Listing Rules, suggesting minimal impact on its operations or stakeholder relations.
More about Adherium Ltd.
Adherium is a leading digital health company specializing in integrated digital health solutions and connected respiratory medical devices. With over 180,000 devices sold globally, the company offers the Hailie® platform, which allows clinicians, healthcare providers, and patients to monitor medication usage and adherence remotely. The platform includes tools for data integration and sharing, enhancing the management of respiratory diseases.
Technical Sentiment Signal: Sell
Current Market Cap: A$8.98M
Learn more about ADR stock on TipRanks’ Stock Analysis page.